RAP 3.57% 14.5¢ resapp health limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-8

  1. 13,204 Posts.
    lightbulb Created with Sketch. 3
    Yep, but there is a big hint in this announcement on what could be expected in near future and when the trial is completed. Good to be caution but big money might try to take small parcel as pilot buy & supply being limited at this price, it could bring provide good appreciation to SP.

    If trial successful as management hinting out, this could re-rate back hard due to current interest in bio sector.

    fingers crossed
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.